GL1X · GenesisL1 explorer

Research workbench

Crystal structure of monoclonal human anti-rhesus D Fc IGG1 T125(YB2/0) double mutant (H310 and H435 in K)

Analyse Crystal structure of monoclonal human anti-rhesus D Fc IGG1 T125(YB2/0) double… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3V8C
Type
protein
Length
421 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Ig gamma-1 chain C region
UniProt
P01857
Ligands
NAG, MAN, GAL
Pockets
2 · best druggability 0.48

Structure

x-ray diffraction · 2 distinct chains · 9% helix, 42% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AIg gamma-1 chain C regionprotein2129% helix, 47% strandP01857
BIg gamma-1 chain C regionprotein20910% helix, 37% strandP01857

Ligands and binding sites

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 8 copies · chains A, B
  • MAN · alpha-D-mannopyranose · sugar · 6 copies · chains B, A
  • GAL · beta-D-galactopyranose · sugar · 2 copies · chains A, B
  • GOL · Glycerol · additive · 3 copies · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12180.480.7433empty
2530.280.7615empty

Interfaces

1 interface between chains.

  • A–B · 1134 Ų buried · 6 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 disulfide (disulfide).

Compared structures

  • 3V8C · Crystal structure of monoclonal human anti-rhesus D Fc IgG1 t125(yb2/0) double mutant… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.